#$%^&*AU2013100008A420130131.pdf#####C:\NRPonb\DCC\DAR\484WSD4_1.DOC410]/2013 ABSTRACT Inhalable formulations of glycopyrronium bromide A unit dosage form of a dry powder formulation of glycopyrronium bromide suitable for administration by inhalation. The unit dosage form comprises a capsule that contains (a) 0.01 to 0.5 mg glycopyrronium bromide(b) 0.01 to 0.1 mg magnesium stearate and (c) 20.00 to 30.00 mg lactose.